MCID: SML008
MIFTS: 33

Small Intestine Lymphoma

Categories: Blood diseases, Cancer diseases, Gastrointestinal diseases, Immune diseases

Aliases & Classifications for Small Intestine Lymphoma

MalaCards integrated aliases for Small Intestine Lymphoma:

Name: Small Intestine Lymphoma 12 15 37
Small Intestinal Lymphoma 12 71

Classifications:



External Ids:

Disease Ontology 12 DOID:13996
NCIt 49 C4007
SNOMED-CT 67 449074003
UMLS 71 C0278805

Summaries for Small Intestine Lymphoma

MalaCards based summary : Small Intestine Lymphoma, also known as small intestinal lymphoma, is related to gastrointestinal lymphoma and lymphoma. An important gene associated with Small Intestine Lymphoma is SPAG11A (Sperm Associated Antigen 11A), and among its related pathways/superpathways are Hematopoietic Stem Cells and Lineage-specific Markers and Primary immunodeficiency. The drugs Oxaliplatin and Clavulanate have been mentioned in the context of this disorder. Affiliated tissues include small intestine, t cells and liver.

Related Diseases for Small Intestine Lymphoma

Diseases related to Small Intestine Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 46)
# Related Disease Score Top Affiliating Genes
1 gastrointestinal lymphoma 29.6 PGLS CD79A
2 lymphoma 10.5
3 alpha chain disease 10.3
4 intestinal disease 10.3
5 alpha-heavy chain disease 10.3
6 intussusception 10.1
7 b-cell lymphoma 10.1
8 lymphoma, hodgkin, classic 10.0
9 lymphoma, non-hodgkin, familial 10.0
10 intestinal obstruction 10.0
11 lymphoma, mucosa-associated lymphoid type 10.0
12 diffuse large b-cell lymphoma 10.0
13 intestinal tuberculosis 10.0
14 ileus 10.0
15 persistent generalized lymphadenopathy 9.9 PGLS CD79A
16 burkitt lymphoma 9.8
17 gastric cancer 9.8
18 inflammatory bowel disease 9.8
19 mantle cell lymphoma 9.8
20 marginal zone b-cell lymphoma 9.8
21 follicular lymphoma 9.8
22 heavy chain disease 9.8
23 lymphoblastic lymphoma 9.8
24 bacterial infectious disease 9.8
25 microinvasive gastric cancer 9.8
26 diarrhea 9.8
27 oral candidiasis 9.8
28 candidiasis 9.8
29 intestinal perforation 9.8
30 constipation 9.8
31 adenocarcinoma 9.8
32 lynch syndrome 9.8
33 lymphopenia 9.8
34 acquired immunodeficiency syndrome 9.8
35 peritonitis 9.8
36 hypereosinophilic syndrome 9.8
37 enteropathy-associated t-cell lymphoma 9.8
38 lymphosarcoma 9.8
39 argyria 9.8
40 overgrowth syndrome 9.8
41 gastric lymphoma 9.8 PGLS CD79A
42 selective igg deficiency disease 9.7 TOR1A CD79A
43 immunoglobulin a deficiency 1 9.7 TOR1A CD79A
44 giardiasis 9.6 TOR1A CD79A
45 microscopic colitis 9.5 TOR1A CD79A
46 immunoglobulin alpha deficiency 9.3 TOR1A CD79A

Graphical network of the top 20 diseases related to Small Intestine Lymphoma:



Diseases related to Small Intestine Lymphoma

Symptoms & Phenotypes for Small Intestine Lymphoma

Drugs & Therapeutics for Small Intestine Lymphoma

Drugs for Small Intestine Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 157)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oxaliplatin Approved, Investigational Phase 4 61825-94-3 43805 6857599 5310940 9887054
2
Clavulanate Approved, Vet_approved Phase 3 58001-44-8 5280980
3
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
4
Ciprofloxacin Approved, Investigational Phase 3 85721-33-1 2764
5 Orange Approved Phase 3
6
Ondansetron Approved Phase 3 99614-02-5 4595
7
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
8
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
9
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
10
Ofloxacin Approved Phase 3 82419-36-1 4583
11
Morphine Approved, Investigational Phase 3 57-27-2 5288826
12
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
13
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
14
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
15
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
16
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
17
Caspofungin Approved Phase 3 162808-62-0, 179463-17-3 2826718 468682
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
19 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
20 Amoxicillin-Potassium Clavulanate Combination Phase 3
21 beta-Lactamase Inhibitors Phase 3
22 Cola Phase 3
23 Antineoplastic Agents, Hormonal Phase 3
24 Gastrointestinal Agents Phase 3
25 Hormones Phase 3
26 Hormone Antagonists Phase 3
27 Anti-Infective Agents Phase 3
28 glucocorticoids Phase 3
29 Anti-Inflammatory Agents Phase 3
30 Anti-Bacterial Agents Phase 3
31 Liver Extracts Phase 3
32 Neurotransmitter Agents Phase 3
33 Anti-Anxiety Agents Phase 3
34 Antiemetics Phase 3
35 Psychotropic Drugs Phase 3
36 Dermatologic Agents Phase 3
37 Antipsychotic Agents Phase 3
38 Cytochrome P-450 Enzyme Inhibitors Phase 3
39 Excitatory Amino Acid Antagonists Phase 3
40 Respiratory System Agents Phase 3
41 Antitussive Agents Phase 3
42 Narcotics Phase 3
43 Analgesics Phase 3
44 Analgesics, Opioid Phase 3
45 Chlorpheniramine, phenylpropanolamine drug combination Phase 3
46 Antifungal Agents Phase 3
47 Amebicides Phase 3
48 Antiparasitic Agents Phase 3
49 Antiprotozoal Agents Phase 3
50 Liposomal amphotericin B Phase 3

Interventional clinical trials:

(show top 50) (show all 67)
# Name Status NCT ID Phase Drugs
1 Study of the Relationship Between the Rate of Residual Platinum in the Blood and the Incidence of Persistent Neurotoxicity in Patients Treated for Gastrointestinal Cancer With Oxaliplatin Unknown status NCT00274885 Phase 4 oxaliplatin
2 A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE] Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
3 A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis Completed NCT00016380 Phase 3 dexamethasone;ondansetron
4 Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer Completed NCT00006348 Phase 3 ondansetron
5 A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors Completed NCT00005590 Phase 3 levofloxacin
6 A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
7 A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials Completed NCT00003938 Phase 3 liposomal amphotericin B
8 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
9 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
10 A Phase II Evaluation of High Dose Chemotherapy and Autologous Stem Cell Transplantation for Intestinal T-cell Lymphomas Unknown status NCT00669812 Phase 2 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;melphalan;methotrexate;prednisolone;vincristine sulfate
11 Pilot Study of Intraperitoneal (IP) Therapy With Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies Completed NCT00005049 Phase 2 carboplatin;cisplatin;floxuridine
12 A Pilot Phase I/II Trial of Enteral Wallstents for Colonic Obstruction in the Setting of Malignancy Completed NCT00004911 Phase 1, Phase 2
13 A Pilot Phase I/II Trial of Enteral Wallstents for Duodenal Obstruction in the Setting of Malignancy Completed NCT00004910 Phase 1, Phase 2
14 Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study Completed NCT00004895 Phase 2 octreotide acetate
15 Phase II Trial of Everolimus (RAD001) in Relapsed/Refractory Lymphoma Completed NCT00436618 Phase 2 Everolimus
16 Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma Completed NCT00079261 Phase 2 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;gemcitabine hydrochloride;prednisone;vincristine sulfate
17 Phase II Study of Weekly Administered High-Dose Pegylated Interferon Alfa-2B (PEGIntron) in Advanced Stage Low Grade Non-Hodgkin's Lymphoma Completed NCT00006039 Phase 2
18 Purine-Analog-Containing Non-Myeloablative Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies and Severe Aplastic Anemia Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
19 Treatment of Patients With Hematological Malignancies Using Marrow Transplantation From Unrelated Donors Incompatible for One HLA Locus Antigen Completed NCT00005804 Phase 2 cyclophosphamide
20 A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin, as Graft-versus-Host Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation Completed NCT00589563 Phase 2 cyclophosphamide;etoposide;fludarabine phosphate;melphalan;methotrexate;sirolimus;tacrolimus
21 A Phase I/II Study of Clofarabine in Patients With Relapsed T-Cell and NK-Cell Lymphomas Active, not recruiting NCT00416351 Phase 1, Phase 2 clofarabine
22 A Phase 2, Open-Label Study to Evaluate the Efficacy and Safety of Patient-Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH (Id-KLH) and Administered With GM-CSF, in Patients With CNS Lymphoma Withdrawn NCT00621036 Phase 2 methotrexate;thiotepa
23 CHOP-Campath, A Pilot Study of CHOP Plus Campath for the Primary Treatment of ALK-ve Peripheral T Cell Lymphoma [CHOP-CAMPATH] Unknown status NCT00562068 Phase 1 cyclophosphamide;doxorubicin hydrochloride;prednisolone;vincristine sulfate
24 A Phase I, Multiple Dose Escalation Trial of Intravenous Humanized Anti-CD3 Antibody (HuM291) in Patients With CD3+ T-cell Lymphomas Completed NCT00006009 Phase 1
25 Histone Deacetylase (HDAC) Inhibition Using Vorinostat (SAHA) After Autologous Hematopoietic Stem Cell Transplantation for High Risk Lymphoma Completed NCT00561418 Phase 1 vorinostat
26 A Phase I Study of Intraperitoneal Oxaliplatin Alone and in Combination With Intraperitoneal Floxuridine and Leucovorin in Patients With Advanced Metastatic Cancer Confined to the Peritoneal Cavity Completed NCT00005860 Phase 1 floxuridine;leucovorin calcium;oxaliplatin
27 Phase I Clinical and Pharmacological Study of Suberoylanilide Hydroxamic Acid- SAHA (MSK390) in Patients With Advanced Solid Tumors Completed NCT00005634 Phase 1 vorinostat
28 Phase I Clinical Study of Every Three Week Irinotecan With Oral Capecitabine Given Twice Daily for Two Weeks Out of Three in Patients With Gastrointestinal and Other Solid Malignancies Completed NCT00003867 Phase 1 capecitabine;irinotecan hydrochloride
29 A Phase I Trial of VNP4010M, A Novel Alkylating Agent for Patients With Advanced or Metastatic Cancer Completed NCT00025129 Phase 1 laromustine
30 Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients Completed NCT00019773 Phase 1 capecitabine;oxaliplatin
31 A Phase I Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Refractory Neoplasms Completed NCT00019344 Phase 1 alvocidib
32 A Phase I Trial of VNP40101M, a Novel Alkylating Agent, Administered Weekly for Patients With Advanced or Metastatic Cancer Completed NCT00049699 Phase 1 laromustine
33 A Phase 1, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 479 in Subjects With Advanced Solid Tumors Completed NCT00562380 Phase 1
34 A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas Completed NCT01273090 Phase 1 imetelstat sodium
35 A Phase I Study Of 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17DMAG) With Evaluation Of Hsp90 Client Proteins In Subjects With Solid Tumors And Lymphomas Completed NCT00088868 Phase 1 alvespimycin hydrochloride
36 A Phase I Study of BMS-247550 (NSC 710428) Given Weekly X 3 Every 4 Weeks in Patients With Advanced Malignancies Completed NCT00006221 Phase 1 ixabepilone
37 A Phase I Dose Escalation to Maximally Tolerated Dose Trial of 5-Azacytidine (5 AC, NSC 102816) in Combination With Sodium Phenylbutyrate (PB, NSC 657802) in Patients With Refractory Solid Tumors Completed NCT00005639 Phase 1 Azacitidine Injection;sodium phenylbutyrate
38 Phase I Evaluation of Topotecan in Combination With Paclitaxel and Carboplatin Completed NCT00005021 Phase 1 carboplatin;paclitaxel;topotecan hydrochloride
39 Phase I Trial of PS-341 in Advanced Cancers Completed NCT00004002 Phase 1 bortezomib
40 A Phase lb Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting Cells Completed NCT00003993 Phase 1 bryostatin 1
41 A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients With Refractory Metastatic Cancer Completed NCT00031941 Phase 1 lenalidomide
42 A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients Completed NCT00019513 Phase 1 fluorouracil;gemcitabine hydrochloride;leucovorin calcium
43 A Phase I Study of ZD0473 and Doxil in Patients With Advanced Refractory Cancer Completed NCT00016172 Phase 1 pegylated liposomal doxorubicin hydrochloride;picoplatin
44 Phase I Study of Irinotecan for Patients With Abnormal Liver or Renal Function or With Prior Pelvic Radiation Therapy Completed NCT00003368 Phase 1 irinotecan hydrochloride
45 A Phase I Clinical Trial To Assess The Safety And Efficacy Of Intraperitoneal PV701 Administrations In Patients With Advanced Or Recurrent Malignancy Largely Confined To The Peritoneal Cavity Completed NCT00055705 Phase 1
46 A Phase I Study Of Medi 522 In Patients With Advanced Tumors Completed NCT00049712 Phase 1
47 A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction Completed NCT00049400 Phase 1 BMS-247550
48 A Pharmacogenetic-Based Phase I Trial of Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in Patients With Advanced Gastrointestinal Cancer Completed NCT00654160 Phase 1 fluorouracil;irinotecan hydrochloride;leucovorin calcium
49 A Combined Rising Single-Dose (RSD) and Rising Multiple-Dose (RMD) Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of KX2-391 in Patients With Advanced Malignancies That Are Refractory to Conventional Therapies Completed NCT00646139 Phase 1 Src kinase inhibitor KX2-391
50 A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES Completed NCT00006340 Phase 1 arginine butyrate;ganciclovir

Search NIH Clinical Center for Small Intestine Lymphoma

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Small Intestine Lymphoma cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Small Intestine Lymphoma:
Hematopoietic stem cells for treatment of hematologic malignancies
Embryonic/Adult Cultured Cells Related to Small Intestine Lymphoma:
Bone marrow-derived hematopoietic stem cells

Genetic Tests for Small Intestine Lymphoma

Anatomical Context for Small Intestine Lymphoma

MalaCards organs/tissues related to Small Intestine Lymphoma:

40
Small Intestine, T Cells, Liver, Bone, Colon, Monocytes, Nk Cells

Publications for Small Intestine Lymphoma

Articles related to Small Intestine Lymphoma:

(show top 50) (show all 109)
# Title Authors PMID Year
1
Upfront Surgery for Small Intestinal Non-Hodgkin's Lymphoma. 61
32234940 2020
2
Double-Balloon Endoscopy-Assisted Balloon Dilation of Strictures Secondary to Small-Intestinal Lymphoma. 61
31288506 2020
3
Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin's Lymphoma of the Duodenum: A SEER Database Analysis. 61
32399459 2020
4
Spectral CT Imaging in the Differential Diagnosis of Small Bowel Adenocarcinoma From Primary Small Intestinal Lymphoma. 61
30803898 2019
5
Invited Commentary on "Spectral CT Imaging in the Differential Diagnosis of Small Bowel Adenocarcinoma From Primary Small Intestinal Lymphoma". 61
30967333 2019
6
Primary small bowel lymphoma presenting as invagination. 61
30664435 2018
7
The role of surgical management in primary small bowel lymphoma: A single-center experience. 61
28751057 2017
8
Identification of Mucosa-Invading and Intravascular Bacteria in Feline Small Intestinal Lymphoma. 61
27627983 2017
9
Diagnosis and treatment for primary small intestinal lymphoma of 59 cases: a follow-up study. 61
26728023 2016
10
Male Syrian Hamsters Experimentally Infected with Helicobacter spp. of the H. bilis Cluster Develop MALT-Associated Gastrointestinal Lymphomas. 61
26348390 2016
11
Ileo-ileal Intussusception and Bowel Obstruction Caused by Plasmablastic Lymphoma of Small Bowel- A Rare Entity in Rare Location. 61
27134931 2016
12
Small intestinal lymphoma in a post-renal transplant patient: a rare case with late presentation. 61
23801239 2014
13
Norwich paediatric triad: malrotation, intussusception and small intestinal lymphoma. 61
25432904 2014
14
[A case of small intestinal lymphoma with ileus requiring surgery during chemotherapy]. 61
25731555 2014
15
Primary extranodal gastrointestinal lymphoma: a single center experience from southern Iran - report of changing epidemiology. 61
25204482 2014
16
Acute abdomen as the first presentation of a malignant lymphoma of the small intestine. 61
25102713 2014
17
Laparoscopic resection of synchronous gastric cancer and primary small intestinal lymphoma: a case report. 61
24876758 2014
18
Comparative study of intestinal tuberculosis and primary small intestinal lymphoma. 61
24764686 2014
19
Ileo-ileal intussusception caused by diffuse large B-cell lymphoma of the ileum. 61
24363540 2013
20
A case of ileal mucosa-associated lymphoid tissue lymphoma accompanied by luminal stricture and arterial spurting. 61
24365736 2013
21
[Ultrasonographic and general pathologic features assessment of small intestinal lymphoma]. 61
23827071 2013
22
Clinical outcome of non-surgical treatment for primary small intestinal lymphoma diagnosed with double-balloon endoscopy. 61
22946663 2013
23
Microscopic polyangiitis complicated with ileal involvement detected by double-balloon endoscopy: a case report. 61
23452722 2013
24
[Differential diagnosis of intestinal tuberculosis and primary small intestinal lymphoma using endoscopy and computerized tomography]. 61
23268270 2012
25
Widespread mismatch repair expression in feline small intestinal lymphomas. 61
22000951 2012
26
[Primary small intestinal lymphoma: epidemiological, histological and therapeutic transition in Tunisia]. 61
22450277 2012
27
[When gluten-free diet does not cure celiac disease]. 61
22667047 2012
28
Diagnostic algorithm to differentiate lymphoma from inflammation in feline small intestinal biopsy samples. 61
21149848 2011
29
[Clinicopathological features of small intestinal tumors]. 61
20716865 2010
30
Ultrasonographic evaluation of the muscularis propria in cats with diffuse small intestinal lymphoma or inflammatory bowel disease. 61
20102493 2010
31
[Experience of the diagnosis and treatment of primary small intestine lymphoma]. 61
20302754 2010
32
Clinical outcome in patients with small-intestinal non-Hodgkin lymphoma. 61
19672778 2009
33
Immunophenotypic and histologic classification of 50 cases of feline gastrointestinal lymphoma. 61
19261637 2009
34
Primary small intestinal lymphoma presenting as a groin abscess. 61
19568563 2009
35
[Double balloon endoscopy as a useful tool for the diagnosis and treatment of four cases of primary small intestinal lymphoma]. 61
17633101 2007
36
Primary gastrointestinal lymphoma--a clinicopathologic study. 61
17883049 2007
37
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. 61
17119030 2006
38
Monitoring nonresponsive patients who have celiac disease. 61
16644460 2006
39
Should adults be screened for celiac disease? What are the benefits and harms of screening? 61
15825117 2005
40
[Establishment and characteristics of orthotopically transplanted model of human primary malignant small intestinal lymphoma in nude mice]. 61
15555333 2004
41
Coeliac disease is the most common cause of chronic diarrhoea in Iran. 61
15201579 2004
42
Primary small intestinal lymphoma without symptom diagnosed by colonoscopy. 61
12702058 2003
43
Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998). 61
11251169 2001
44
[Comparative diagnostic value of data of intestinoscopy with biopsy obtained from different regions of the small intestine]. 61
11599264 2001
45
A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. 61
10640959 2000
46
Perforation of jejunal lymphoma--ultrasonographic diagnosis of free air over left flank area. 61
10522014 1999
47
Coeliac disease detected by screening is not silent--simply unrecognized. 61
10024951 1998
48
Fatal intestinal hemorrhage complicating ileal lymphoma after cyclosporine for unresponsive celiac disease. 61
9356852 1997
49
Immunoproliferative small intestinal disease and primary small intestinal lymphoma: review of literature. 61
9339621 1997
50
[Immunoproliferative small intestinal disease (IPSID): IPSID-like lymphomas, IPSID equivalents?, in 12 Spanish patients]. 61
8850232 1995

Variations for Small Intestine Lymphoma

Expression for Small Intestine Lymphoma

Search GEO for disease gene expression data for Small Intestine Lymphoma.

Pathways for Small Intestine Lymphoma

Pathways related to Small Intestine Lymphoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.02 CD79A CD3E
2 10.2 CD79A CD3E

GO Terms for Small Intestine Lymphoma

Biological processes related to Small Intestine Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 8.62 SPAG11B SPAG11A

Molecular functions related to Small Intestine Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transmembrane signaling receptor activity GO:0004888 8.8 CD79A CD72 CD3E

Sources for Small Intestine Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....